THE RELATIVE RISK OF DEVELOPING TYPE 2 DIABETES MELLITUS IN YOUNG ADULTS WITH SCHIZOPHRENIA TREATED WITH DIFFERENT ATYPICAL ANTIPSYCHOTIC

  • Nicolae-Marius Cason
  • Petru Aurel Babeș
  • Enikő Béres
  • Katalin Babeș Clinical Emergency Hospital of Oradea
Keywords: Schizophrenia, Young Adult, Second-generation Antipsychotic Agents, Metabolic Side Effects of Drugs and Substances, Diabetes Mellitus Type 2, Olanzapine

Abstract

Background and aim: While the link between antipsychotic treatment and metabolic adverse events, including type 2 diabetes mellitus (T2DM) are clear in adults with schizophrenia, in young this association is not so well studied although the use of second generation antipsychotics (SGA) is more and more frequent. Material and methods: The local diabetes register was compared with the list of all registered young adults (18-35 years) with schizophrenia 2 years retrospective and 2 years prospective. Cumulative incidence, rate of incidence and relative risk was calculated knowing the number of persons in this age group within this region. Results and discussion: Cumulative incidence for exposed group was 0.7% with a rate of incidence of 6.27 (95%CI: 4.1-10.5) per 1,000 patient-years, when in normal population was 0.2%, respectively 2.01 (95%CI: 0.72-3.79). This means a relative risk of 3.4736 (95%CI: 1.79-6.72), p=0.0002 and NNH=202 (95%CI: 134-404). Multivariate analysis showed that gender male (OR=1.83; 95%CI: 0.9-2.7; p=0.002) and olanzapine prescription (OR=4.76; 95%CI: 1.7-7.7; p=0.0001) were independent risk factors for T2DM. Conclusions: The metabolic risk should be taken in account every time introducing or changing a SGA in young schizophrenic patient, balancing the benefits and negative metabolic effects (especially with olanzapine). Healthy nutrition and physical activities are necessary components of these patients lifestyle to avoid early onset of T2DM.

Published
2020-02-01
How to Cite
Cason, Nicolae-Marius, Petru Aurel Babeș, Enikő Béres, and Katalin Babeș. 2020. “THE RELATIVE RISK OF DEVELOPING TYPE 2 DIABETES MELLITUS IN YOUNG ADULTS WITH SCHIZOPHRENIA TREATED WITH DIFFERENT ATYPICAL ANTIPSYCHOTIC”. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 26 (4), 445-53. http://rjdnmd.org/index.php/RJDNMD/article/view/708.
Section
Original Research Articles